ALL
Showing 26 - 47 of 47
ALL, Burkitt's Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (Rapamycin + high dose etoposide and cytarabine)
Terminated
- ALL
- +3 more
- Rapamycin + high dose etoposide and cytarabine
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Abramson Cancer Center
Apr 15, 2020
Hodgkin Lymphoma, Lymphocytic Leukemia, Mixed Cell Leukemia Trial run by the NCI (Stem cell transplantation)
Completed
- Hodgkin Lymphoma
- +8 more
- Stem cell transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019
AML, ALL, Undifferentiated Leukemia Trial in Boston (Abatacept)
Completed
- AML
- +11 more
-
Boston, MassachusettsBoston Children's Hospital
Oct 31, 2019
Breast Cancer, ALL, Lung Cancer Trial in Belgium (Implementation of a care pathway)
Recruiting
- Breast Cancer
- +5 more
- Implementation of a care pathway
-
Turnhout, Antwerpen, Belgium
- +3 more
Apr 15, 2019
Relapsed/Refractory AML, Relapsed/Refractory ALL, Secondary AML/MDS Trial in Canada, United States (Plerixafor Dose Escalation)
Completed
- Relapsed/Refractory AML
- +5 more
- Plerixafor Dose Escalation
-
Phoenix, Arizona
- +8 more
Sep 5, 2018
Methotrexate Induced Gastrointestinal Intolerance in Juvenile
Completed
- Juvenile Idiopathic Arthritis
- ALL
- (no location specified)
Aug 16, 2018
MDS, AML, ALL Trial in France (Clofarabine in combination with IV busulfan and ATG)
Completed
- MDS
- +3 more
- Clofarabine in combination with IV busulfan and ATG
-
Lyon, France
- +5 more
Jul 18, 2017
All Trial in Boston (Re-Engineered Hospital Discharge)
Completed
- All
- Re-Engineered Hospital Discharge
-
Boston, MassachusettsBoston Medical center
Feb 27, 2017
Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (radiation, biological, drug)
Terminated
- Hematologic Malignancy
- +11 more
- Total Body Irradiation (TBI)
- +5 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Oct 19, 2016
CML, AML, MDS Trial in Philadelphia (Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells, Observation Arm)
Completed
- CML
- +6 more
- Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells
- Observation Arm
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Aug 17, 2016
AML, ALL, CLL Trial in Boston (Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF)
Completed
- AML
- +8 more
- Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jul 14, 2016
AML, ALL, Blast Crisis Trial in United States (TG02 citrate, Carfilzomib, Dexamethasone)
Completed
- AML
- +4 more
- TG02 citrate
- +2 more
-
Denver, Colorado
- +8 more
May 5, 2016
Photochemotherapy and Graft-versus-leukemia in Acute-leukemia
Completed
- ALL
- +3 more
- Photochemotherapy
-
Stockholm, SwedenDepartment of Dermatology, Karolinska University Hospital Huddin
Dec 11, 2015
ALL Trial in Boston (Music Therapy, Massage Therapy)
Completed
- ALL
- Music Therapy
- Massage Therapy
-
Boston, MassachusettsBoston Medical Center
Jan 27, 2015
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Blast-phase Chronic Myelogenous Leukemia Trial in Tampa, Baltimore, Durham
Completed
- Acute Myeloid Leukemia
- +5 more
- STA-9090 (ganetespib)
-
Tampa, Florida
- +2 more
Sep 17, 2014
ALL, ANLL, MDS Trial (Naive T-cell Depleted Stem Cell Transplant, Stem Cell Transplant No Manipulation, Isolex device from
Terminated
- ALL
- +3 more
- Naive T-cell Depleted Stem Cell Transplant
- +2 more
- (no location specified)
Sep 25, 2013
Unrelated Stem Cell Transplantation for Hematopoietic Disorders
Completed
- CML
- +5 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 1, 2013
Hematologic Malignancy, AML, ALL Trial in Boston (CD+8 T cell depletion)
Completed
- Hematologic Malignancy
- +6 more
- CD+8 T cell depletion
-
Boston, Massachusetts
- +1 more
Mar 15, 2012
AML, MDS, ALL Trial in Seoul (fludarabine phosphate, busulfan)
Unknown status
- AML
- +4 more
- fludarabine phosphate, busulfan
-
Seoul, Korea, Republic ofDong Hwan Kim
Dec 29, 2008